CLINICAL_TRIALS
trial_result
· 2022-02-18
Clinical Trial Update: Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic Leukemia [Phase 2]
Summary
Phase 2 clinical trial evaluating ponatinib in combination with chemotherapy for young adults with Philadelphia chromosome-positive acute lymphoblastic leukemia…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PETHEMA Foundation | Conditions: ALL | Phase 2 | Status: UNKNOWN